Palm Beach Gardens Medical Center Earns Blue Distinction® Center+ Designation for Quality and Cost-Efficiency in Knee and Hip Replacement Surgeries

Blue Cross and Blue Shield Association [BCBSA] selects Palm Beach Gardens Medical Center as a Blue Distinction Center+ for Knee and Hip Replacement, part of the Blue Distinction Specialty Care program.

Blue Distinction Centers are nationally designated healthcare facilities that show a commitment to delivering high-quality patient safety and better health outcomes, based on objective measures that were developed with input from the medical community and leading accreditation and quality organizations.

“Palm Beach Gardens Medical Center is proud to be recognized by BCBSA for meeting the robust selection criteria for knee and hip replacements set by the Blue Distinction Specialty Care program”, said Teresa Urquhart, chief executive officer for Palm Beach Gardens Medical Center. “This designation is a testament to the hard work and dedication our orthopedic medical staff provides to each patient who is treated at our hospital. We could not be more grateful for this accomplishment.”

Facilities designated as Blue Distinction Centers® for Knee and Hip Replacement demonstrate expertise in total knee and total hip replacement surgeries, resulting in fewer patient complications and hospital readmissions. Designated facilities include hospitals (with and without an onsite Intensive Care Unit) and Ambulatory Surgery Centers (ASC).

All designated facilities must maintain national accreditation, and ASCs are also required to have an advanced orthopedic certification. In addition to meeting these quality thresholds, hospitals designated as Blue Distinction Centers+ are on average 20 percent more cost-efficient in an episode of care compared to other facilities. Quality is key: only those facilities that first meet nationally established, objective quality measures will be considered for designation as a Blue Distinction Center+.

For more information about our orthopedics program and services, go to www.pbgmc.com/services/orthopedics or call 561-622-1411.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy